When we examined the patients under NA treatment, namely the CH and LC groups, the patients who developed HCC were older, had higher levels of FIB-4 index, M2BPGi, and AFP, and had lower levels of albumin and platelet counts (S2 Table), consistent with the previous findings, mentioned above. The gene discussed is ALB; the disease is laryngotracheoesophageal cleft.